AYTU BioPharma, Inc. Common Stock
AYTUAYTU BioPharma, Inc. is a biopharmaceutical company focused on developing and commercializing a portfolio of therapies for rare and specialty conditions. The company markets oral formulations of testosterone and other hormone-based treatments, aiming to address hormonal deficiencies and related health issues. Founded with a focus on innovation in hormone therapy, AYTU aims to expand its product offerings and pipeline to serve underserved patient populations.
Company News
The 73rd Emerging Growth Conference is scheduled for July 17-18, 2024, featuring presentations from various companies in the healthcare, technology, and energy sectors.
Shares of Shapeways Holdings, Inc. (NASDAQ: SHPW) tumbled during Wednesday’s session following downbeat results. Shapeways Hldgs posted an adjusted loss of $1.36 per share, versus market expectations for a loss of 95 cents per share. The company’s quarterly sales came in at $8.37 million versus estimates of $8.75 million. Shapeways shares fel...
Gainers Bionomics Limited (NASDAQ: BNOX) shares jumped 308% to $4.00 after the company announced the ATTUNE trial met its primary endpoint showing BNC210 treatment led to a statistically significant reduction in total PTSD symptom severity at 12 weeks. Baudax Bio, Inc. (NASDAQ: BXRX) gained 109% to $0.6287 after the company announced it was gr...
Best penny stocks to buy? 4 with news to watch this week The post Best Penny Stocks? 4 Hot Stocks With News This Week appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
Upgrades According to B. Riley Securities, the prior rating for Mirati Therapeutics Inc (NASDAQ:MRTX) was changed from Neutral to Buy. In the second quarter, Mirati Therapeutics showed an EPS of $3.04, compared to $3.18 from the year-ago quarter. The stock has a 52-week-high of $101.20 and a 52-week-low of $27.30. At the end of the last trading p...
